BioSpace News Archive

Business

Windtree Therapeutics Reports Fourth Quarter and Year-End 2021 Financial Results and Provides Key Business Updates

Windtree Therapeutics, Inc. (NasdaqCM: WINT), a biotechnology company focused on advancing multiple late-stage interventions for acute cardiovascular and pulmonary disorders, today reported financial results for the fourth quarter and year ended December 31, 2021 and provided key business updates.

March 31, 2022
·
12 min read
Pharm Country

Trevena Receives up to $40M in OLINVYK ex-US Royalty-Based Financing from R-Bridge Healthcare Fund, an affiliate of CBC Group

Trevena, Inc., a biopharmaceutical company focused on the development and commercialization of novel medicines for patients with central nervous system disorders, announced that the Company entered into a royalty-based financing with an affiliate of R-Bridge Healthcare Fund.

March 31, 2022
·
6 min read
Drug Development

Genprex Announces the Opening for Enrollment of its Phase 1/2 Acclaim-2 Clinical Trial of REQORSA™ Immunogene Therapy in Combination With Keytruda® to Treat Non-Small Cell Lung Cancer

Genprex Announces the Opening for Enrollment of its Phase 1/2 Acclaim-2 Clinical Trial of REQORSA™ Immunogene Therapy in Combination With Keytruda® to Treat Non-Small Cell Lung Cancer.

March 31, 2022
·
7 min read
Business

Organon Enters into Global License Agreement to Commercialize Daré Bioscience’s XACIATO™ (clindamycin phosphate vaginal gel, 2%), FDA-Approved Treatment for Females 12 and Older with Bacterial Vaginosis (BV)

Organon and Daré Bioscience, Inc. today announced they have entered into an agreement whereby Organon will license global rights to XACIATO (clindamycin phosphate vaginal gel, 2%). XACIATO is an FDA-approved medication for the treatment of bacterial vaginosis (BV) in females 12 years of age and older.

March 31, 2022
·
8 min read
Business

Channel Medsystems Announces Appointment of Three Key Executives to Management Team and Expanded Launch of Cerene® Cryotherapy for Heavy Menstrual Bleeding

Channel Medsystems, Inc. today announced the appointment of three new executive team members to amplify its commercialization efforts.

March 31, 2022
·
4 min read
Business

AlloVir Appoints Shawn Tomasello to Its Board of Directors

AlloVir today announced the appointment of Shawn Tomasello to its Board of Directors.

March 31, 2022
·
4 min read
Business

South Rampart Pharma Appoints Robert Dickey, MBA, as Chief Financial Officer

South Rampart Pharma today announced the appointment of Robert Dickey, MBA, as its Chief Financial Officer.

March 31, 2022
·
3 min read
Business

Taysha Gene Therapies Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Update

Taysha Gene Therapies, Inc. today reported financial results for the fourth quarter and full-year ended December 31, 2021 and provided a corporate update.

March 31, 2022
·
14 min read
Aptose to Present at Canaccord Genuity’s 2022 Horizons in Oncology Virtual Conference

Aptose Biosciences Inc. today announced that William G. Rice, Ph.D., Chairman, President and Chief Executive Officer, will participate in a panel to discuss new approaches of treating acute myeloid leukemias (AML) at Canaccord Genuity’s 2022 Horizons in Oncology Virtual Conference.

March 31, 2022
·
1 min read
Bio NC

Incyclix Bio Announces $30 Million Series B Financing Led by Boxer Capital

Incyclix Bio, LLC today announced the closing of a $30 million Series B financing led by new investor Boxer Capital.

March 31, 2022
·
3 min read